Pathogenic models of Alzheimer’s disease emphasize a precipitating role of Aβ that leads to tau pathology and subsequent neurodegeneration6; however, we found that tau pathology did not appear to exert a direct effect on neurodegeneration until elevated by both cerebrovascular disease and astrocytosis. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.